{"name":"Matthew Neal MD","slug":"matthew-neal-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"theraputic heparin","genericName":"theraputic heparin","slug":"theraputic-heparin","indication":"Other","status":"marketed"},{"name":"Metformin ER","genericName":"Metformin ER","slug":"metformin-er","indication":"Other","status":"marketed"},{"name":"P2Y12","genericName":"P2Y12","slug":"p2y12","indication":"Other","status":"marketed"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Crizanlizumab Injection","genericName":"Crizanlizumab Injection","slug":"crizanlizumab-injection","indication":"Sickle cell disease (reduction of vaso-occlusive crises in patients 16 years and older)","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"prophylactic heparin","genericName":"prophylactic heparin","slug":"prophylactic-heparin","indication":"Prophylaxis of venous thromboembolism in surgical patients","status":"marketed"}]}],"pipeline":[{"name":"theraputic heparin","genericName":"theraputic heparin","slug":"theraputic-heparin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Crizanlizumab Injection","genericName":"Crizanlizumab Injection","slug":"crizanlizumab-injection","phase":"marketed","mechanism":"Crizanlizumab is a monoclonal antibody that binds to P-selectin on the surface of platelets and endothelial cells, blocking platelet-endothelial interactions and reducing vaso-occlusive crises in sickle cell disease.","indications":["Sickle cell disease (reduction of vaso-occlusive crises in patients 16 years and older)"],"catalyst":""},{"name":"Metformin ER","genericName":"Metformin ER","slug":"metformin-er","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"P2Y12","genericName":"P2Y12","slug":"p2y12","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"prophylactic heparin","genericName":"prophylactic heparin","slug":"prophylactic-heparin","phase":"marketed","mechanism":"Prophylactic heparin inhibits blood clotting by enhancing the activity of antithrombin III, preventing thrombus formation.","indications":["Prophylaxis of venous thromboembolism in surgical patients","Prophylaxis of thromboembolism in medical patients at risk","Prevention of clotting in extracorporeal circulation"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE9TRVlITnF0QVI3Tm1nTFZTWXVoRm5TbFc4TFkzYmFTcGg1UF9OdF96Nm5hVUpNTkVOR0RfWFc2dURodUN6dTc3dk1ucVVwRTBtQ1I3eTBfYnZvRXVQU0UxWUtkMA?oc=5","date":"2025-01-13","type":"trial","source":"StudyFinds","summary":"Deadly blood clots affect 22 million yearly — Could light therapy be the answer? - StudyFinds","headline":"Deadly blood clots affect 22 million yearly — Could light therapy be the answer?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1YcVJEVzdLek1pTUtHcUhIWVB6YUNfS1hhTFRhenZISl9HUVZsNHRBQTdjU00zTXJQQndYZ0N0OEUxQWlOQ1E1Zl9DNzFZT0tyNnBjYVRCTWpELVFkR05rMTZQRm85NDRJV2t5VjcxWnhhSG96c3B0RUZsREk1ZjQ?oc=5","date":"2025-01-10","type":"pipeline","source":"Medical Xpress","summary":"Red light linked to lowered risk of blood clots - Medical Xpress","headline":"Red light linked to lowered risk of blood clots","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"marketed":5},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}